BACKGROUND/AIMS: We hypothesized that inflammatory markers are cross-sectionally and longitudinally associated with neuropsychological indicators of early ischemia and Alzheimer's disease. METHODS: Framingham Offspring Study participants, free of clinical stroke or dementia (n = 1,878; 60 ± 9 years; 54% women), underwent neuropsychological assessment and ascertainment of 11 inflammatory markers. Follow-up neuropsychological assessments (6.3 ± 1.0 years) were conducted on 1,352 of the original 1,878 participants. RESULTS: Multivariable linear regression related the inflammatory markers to cross-sectional performance and longitudinal change in neuropsychological performances. Secondary models included a twelfth factor, tumor necrosis factor-α (TNF-α), available on a subset of the sample (n = 1,393 cross-sectional; n = 1,213 longitudinal). Results suggest a few modest cross-sectional inflammatory and neuropsychological associations, particularly for tests assessing visual organization (C-reactive protein, p = 0.007), and a few modest relations between inflammatory markers and neuropsychological change, particularly for executive functioning (TNF-α, p = 0.004). Secondary analyses suggested that inflammatory markers were cross-sectionally (TNF-α, p = 0.004) related to reading performance. CONCLUSIONS: Our findings are largely negative, but suggest that specific inflammatory markers may have limited associations with poorer cognition and reading performance among community-dwelling adults. Because of multiple testing concerns, our limited positive findings are offered as hypothesis generating and require replication in other studies.
BACKGROUND/AIMS: We hypothesized that inflammatory markers are cross-sectionally and longitudinally associated with neuropsychological indicators of early ischemia and Alzheimer's disease. METHODS: Framingham Offspring Study participants, free of clinical stroke or dementia (n = 1,878; 60 ± 9 years; 54% women), underwent neuropsychological assessment and ascertainment of 11 inflammatory markers. Follow-up neuropsychological assessments (6.3 ± 1.0 years) were conducted on 1,352 of the original 1,878 participants. RESULTS: Multivariable linear regression related the inflammatory markers to cross-sectional performance and longitudinal change in neuropsychological performances. Secondary models included a twelfth factor, tumor necrosis factor-α (TNF-α), available on a subset of the sample (n = 1,393 cross-sectional; n = 1,213 longitudinal). Results suggest a few modest cross-sectional inflammatory and neuropsychological associations, particularly for tests assessing visual organization (C-reactive protein, p = 0.007), and a few modest relations between inflammatory markers and neuropsychological change, particularly for executive functioning (TNF-α, p = 0.004). Secondary analyses suggested that inflammatory markers were cross-sectionally (TNF-α, p = 0.004) related to reading performance. CONCLUSIONS: Our findings are largely negative, but suggest that specific inflammatory markers may have limited associations with poorer cognition and reading performance among community-dwelling adults. Because of multiple testing concerns, our limited positive findings are offered as hypothesis generating and require replication in other studies.
Authors: Jennifer J Manly; Diane M Jacobs; Pegah Touradji; Scott A Small; Yaakov Stern Journal: J Int Neuropsychol Soc Date: 2002-03 Impact factor: 2.892
Authors: Demosthenes B Panagiotakos; Christos E Pitsavos; Christina A Chrysohoou; John Skoumas; Marina Toutouza; Dennis Belegrinos; Pavlos K Toutouzas; Christodoulos Stefanadis Journal: Ann Epidemiol Date: 2004-03 Impact factor: 3.797
Authors: Chad H Moritz; Sterling C Johnson; Kathryn M McMillan; Victor M Haughton; M Elizabeth Meyerand Journal: J Int Neuropsychol Soc Date: 2004-11 Impact factor: 2.892
Authors: E Tarkowski; L Rosengren; C Blomstrand; C Wikkelsö; C Jensen; S Ekholm; A Tarkowski Journal: Clin Exp Immunol Date: 1997-12 Impact factor: 4.330
Authors: Snorri B Rafnsson; Ian J Deary; Felicity B Smith; Martha C Whiteman; Ann Rumley; Gordon D O Lowe; F Gerald R Fowkes Journal: J Am Geriatr Soc Date: 2007-05 Impact factor: 5.562
Authors: I L Campbell; C R Abraham; E Masliah; P Kemper; J D Inglis; M B Oldstone; L Mucke Journal: Proc Natl Acad Sci U S A Date: 1993-11-01 Impact factor: 11.205
Authors: Renate Schnabel; Martin G Larson; Josée Dupuis; Kathryn L Lunetta; Izabella Lipinska; James B Meigs; Xiaoyan Yin; Jian Rong; Joseph A Vita; Christopher Newton-Cheh; Daniel Levy; John F Keaney; Ramachandran S Vasan; Gary F Mitchell; Emelia J Benjamin Journal: Hypertension Date: 2008-04-21 Impact factor: 10.190
Authors: Rhoda Au; Sudha Seshadri; Philip A Wolf; Merrill Elias; Penelope Elias; Lisa Sullivan; Alexa Beiser; Ralph B D'Agostino Journal: Exp Aging Res Date: 2004 Oct-Dec Impact factor: 1.645
Authors: Tom Jeerakathil; Philip A Wolf; Alexa Beiser; Joseph Massaro; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli Journal: Stroke Date: 2004-06-24 Impact factor: 7.914
Authors: Jimmy Akrivos; Ramit Ravona-Springer; James Schmeidler; Derek LeRoith; Anthony Heymann; Rachel Preiss; Hadas Hoffman; Keren Koifman; Jeremy M Silverman; Michal Schnaider Beeri Journal: Int J Geriatr Psychiatry Date: 2015-02-20 Impact factor: 3.485
Authors: Mike F Schmidt; Kevin B Freeman; Beverly G Windham; Michael E Griswold; Iftikhar J Kullo; Stephen T Turner; Thomas H Mosley Journal: J Am Geriatr Soc Date: 2016-08-22 Impact factor: 5.562